作者：
Alberto,Vogrig [1]
;
Antoine,Pegat [2]
;
Macarena,Villagrán-García [3]
;
Valentin,Wucher [3]
;
Valéry,Attignon [4]
;
Emilie,Sohier [5]
;
Marie,Brevet [6]
;
Veronique,Rogemond [3]
;
Anne-Laurie,Pinto [3]
;
Sergio,Muñiz-Castrillo [7]
;
Elise,Peter [3]
;
Melisse,Robert [3]
;
Géraldine,Picard [3]
;
Lucie,Hopes [8]
;
Dimitri,Psimaras [9]
;
Anthony,Terra [10]
;
Corinne,Perrin [10]
;
Dominique,Cogne [11]
;
Severine,Tabone-Eglinger [11]
;
Séverine,Martinez [11]
;
Delphine,Jury [11]
;
Julie,Valantin [12]
;
Nicolas,Gadot [12]
;
Jessie,Auclair-Perrossier [4]
;
Alain,Viari [13]
;
Bertrand,Dubois [14]
;
Virginie,Desestret [3]
;
Jérôme,Honnorat [3]
作者单位：
French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.;Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.;Clinical Neurology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.;Department of Medicine (DAME), University of Udine, Udine, Italy.
[1]
Service ENMG et Pathologies Neuromusculaires, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Bron, France.;Pathophysiology and Genetics of Neuron and Muscle, CNRS UMR 5261, INSERM U1315, INMG, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.
[2]
French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.;Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
[3]
Cancer Genomic Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.
[4]
Gilles Thomas Bioinformatics Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.;Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.
[5]
Department of Pathology, Lyon Est Hospital, Hospices Civils de Lyon, Bron, France.
[6]
French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.;Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.;Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, USA.
[7]
Department of Neurology, CHRU Nancy, Nancy, France.
[8]
Neurology 2 Department Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.;Sorbonne Université, INSERM, CNRS, Paris Brain Institute, Institut du Cerveau et de la Moelle Épinière, ICM, Paris, France.
[9]
Centre de Ressources Biologiques Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.
[10]
Plateforme de Gestion des Echantillons Biologique, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.
[11]
Plateforme Anatomopathologie Recherche, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS Centre Léon Bérard, Lyon, France.
[12]
Gilles Thomas Bioinformatics Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.
[13]
Cancer Immune Surveillance and Therapeutic Targeting Team, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.;Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Lyon, France.
[14]
DOI
10.1002/ana.26784
PMID
37638563
发布时间
2024-08-30
换一批
换一批
